Amgen Inc (AMGN) is demonstrating impressive financial strength, with a market cap of $184.67B and an EPS growth of 88.56% year-over-year. The current price of $342.57 reflects a slight decline of 1.54% but remains significantly below its 52-week high of $391.29, indicating potential upside. The company's P/E ratio of 24.05 suggests reasonable valuation against its robust revenue growth of 9.95%, making it an attractive investment opportunity.